Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
NCT06197269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2024-08-13
Summary
Objective of the study is to compare the efficacy and safety of 'Short duration antibiotic' (72hrs) and 'Standard duration antibiotic'(5 - 7days) in preterm neonates ( \>28weeks and \>1000grams ) with culture negative early onset sepsis.
Conditions
- Early-Onset Neonatal Sepsis
- Antibiotic Stewardship
Interventions
- OTHER
-
Short duration antibiotics
antibiotic therapy will be stopped at the time of randomization i.e. 72 hrs after starting treatment
- OTHER
-
Standard duration antibiotics
Antibiotics will be continued for 5-7 days more, 72 hrs after starting treatment.
Sponsors & Collaborators
-
Lady Hardinge Medical College
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 28 Weeks
- Max Age
- 36 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-15
- Primary Completion
- 2024-02-14
- Completion
- 2024-04-14
Countries
- India
Study Locations
More Related Trials
-
NICU Antibiotics and Outcomes Trial
NCT03997266 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor
NCT01290003 ·Status: COMPLETED ·Phase: NA
-
Early Antibiotic Therapy and Vaccination
NCT04109833 ·Status: UNKNOWN
-
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
NCT00189384 ·Status: UNKNOWN ·Phase: PHASE3
-
Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis
NCT06845332 ·Status: RECRUITING
-
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
NCT00873327 ·Status: COMPLETED ·Phase: PHASE1
-
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age
NCT05856227 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants
NCT00942149 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS
NCT06058819 ·Status: RECRUITING
-
Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China
NCT05089760 ·Status: UNKNOWN
-
Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis
NCT03453177 ·Status: COMPLETED ·Phase: PHASE2
-
Reduction of Intravenous Antibiotics In Neonates
NCT03247920 ·Status: COMPLETED ·Phase: PHASE4
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes
NCT02819570 ·Status: UNKNOWN ·Phase: PHASE4
-
Neonatal Bacterial Colonization Study
NCT03896893 ·Status: UNKNOWN ·Phase: NA
-
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
NCT02210169 ·Status: COMPLETED ·Phase: NA
-
Antibiotic Durations for Gram-negative Bacteremia
NCT03101072 ·Status: COMPLETED ·Phase: NA
-
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
NCT06002295 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes
NCT07148622 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset Sepsis
NCT01551394 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
NCT00850122 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Dosing of Vancomycin in Young Infants With Infections
NCT04044703 ·Status: COMPLETED ·Phase: PHASE4
-
Short-term Antibiotic Therapy for Pyelonephritis in Childhood
NCT00724256 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children
NCT03221504 ·Status: UNKNOWN ·Phase: NA